New Blood Biomarker for Alzheimer's Disease via ELISA
Alzheimer's Disease (AD) is the main neurodegenerative disease worldwide affecting more than 15 Mill. people. An easy AD blood diagnostic method does not exist, as well as an early predictive AD biomarker. Scientists of the University of Göttingen identified a novel Blood Biomarker for the Diagnosis of Alzheimer's Disease (AD) which correlates with the cognitive status of individuals at risk to develop AD including mild cognitive impairment (MCI) patients, as well as a corresponding ELISA methodology.
Further Information: PDF
MBM ScienceBridge GmbH
Phone: (0551) 30724-152
Contact
Dr. Jens-Peter Horst
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Recovering phosphorus from sewage sludge ash
Chemical and heat treatment of sewage sludge can recover phosphorus in a process that could help address the problem of diminishing supplies of phosphorus ores. Valuable supplies of phosphorus could…
Efficient, sustainable and cost-effective hybrid energy storage system for modern power grids
EU project HyFlow: Over three years of research, the consortium of the EU project HyFlow has successfully developed a highly efficient, sustainable, and cost-effective hybrid energy storage system (HESS) that…
After 25 years, researchers uncover genetic cause of rare neurological disease
Some families call it a trial of faith. Others just call it a curse. The progressive neurological disease known as spinocerebellar ataxia 4 (SCA4) is a rare condition, but its…
